| Atorvastatin Impurity 17 |
阿托伐他汀杂质17 |
1331869-19-2 |
| Carbamazepine Impurity 6 |
卡马西平杂质6 |
132648-81-8 |
| Cefotaxime Impurity 6 |
头孢曲松杂质6 |
123238-79-9 |
| Pazopanib Impurity 22 |
Pazopanib Impurity 22 |
1226500-01-1 |
| Crisaborole intermediate |
克立硼罗中间体 |
1187188-60-8 |
| Nifedipine Impurity J |
硝苯地平杂质J |
114709-68-1 |
| Gliclazide iMpurity D |
格列齐特杂质D |
1136426-19-1 |
| Sorafenib β-D-Glucuronide |
索拉非尼杂质23 |
1130164-93-0 |
| NMP-ACA (Cefepime Impurity) |
1-[[(6R,7R)-7-氨基-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基]甲基]-1-甲基吡咯烷内盐 |
103296-32-8 |
| m-Loxoprofen |
间洛索洛芬 |
1026471-88-4 |
| Indacaterol Impurity 12 |
茚达特罗杂质12 |
1026461-20-0 |
| 5-METHOXY-1H-BENZIMIDAZOLE-2-SULFONIC ACID |
5-甲氧基-1H-苯并咪唑-2-磺酸 |
106135-28-8 |
| 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid |
5-氯-4-氨基-2,3-二氢苯并呋喃-7-甲酸 |
182808-04-4 |
| Carbamic acid, N-ethyl-N-methyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, hydrochloride (1:1) |
氨基甲酸,N-乙基-N-甲基-,3-[1-(二甲基氨基)乙基]苯基酯,盐酸盐(1：1) |
105601-14-7 |
| (S)-alpha.-(aminomethyl)-3-hydroxybenzyl alcohol hydrochloride |
苯肾上腺素杂质 |
43090-68-2 |
| Cefuroxime Sodium EP Impurity F |
头孢呋辛钠EP杂质F |
97170-19-9 |
| Loxoprofen Impurity 15 |
洛索洛芬杂质15 |
1091621-62-3 |
| Tadalafil Impurity 19 |
Tadalafil Impurity 19 |
477970-21-1 |
| (S)-5-bromo-6-methoxy-alpha-methylnaphthalene-1-acetic acid |
萘普生杂质 |
84236-26-0 |
| (1R,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester |
他达拉非杂质24 |
171596-44-4 |
